Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL11203324 | 0.98 | HDAC8 (0.40) | HDAC8RAB9ASMN1; SMN2NPC1POLB | |
| Hydrochloric Acid SCHEMBL10708206 | 0.98 | HDAC8 (0.40) | HDAC8RAB9ASMN1; SMN2NPC1POLB | |
| SCHEMBL29561298 | 0.76 | — | — | |
| SCHEMBL329286 | 0.76 | — | — | |
| Bromide SCHEMBL636756 | 0.74 | — | — | |
| Fluoride Ion SCHEMBL12474461 | 0.74 | — | — | |
| Water SCHEMBL31387974 | 0.74 | — | — | |
| Iodide SCHEMBL1807663 | 0.74 | — | — | |
| Water SCHEMBL9746989 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL339345 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633891-B2 | Protrusion pattern forming device with display function | SONY CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110012828-A1 | PROTRUSION PATTERN FORMING DEVICE WITH DISPLAY FUNCTION | SONY CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-7488819-B2 | Multidentate ligand | FUJITSU LIMITED (JP) | 2009-02-10 | — | — | US | disclosed |
| US-20050054849-A1 | Multidentate ligand, polynuclear metal complex, metal complex chain, metal complex assembly and production thereof | FUJITSU LIMITED (JP) | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054849-A1 | Multidentate ligand, polynuclear metal complex, metal complex chain, metal complex assembly and production thereof | IMMT, MICOS13, AP3M1 | HDAC8 4417/4885RAB9A 3393/4885SMN1; SMN2 2357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.